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In Brief
The function of IgD has been mysterious. Shan et al. find that IgD recognized food antigens and targeted basophils through galectin-9. IgD ligation by antigen induced basophil secretion of IL-4, IL-5, and IL-13, which amplified Th2 cellmediated IgG1 and IgE production by B cells. IgD also constrained IgEmediated basophil degranulation.
INTRODUCTION
B cells of the adaptive immune system generate humoral protection by releasing immunoglobulin M (IgM), IgG, IgA, and IgE. Each of these antibodies consists of variable (V) heavy (H) and light (L) chain regions, which recognize antigen, and an H chain constant (C) region, which mediates specific biological functions (Lu et al., 2018) . Besides co-opting soluble innate effector proteins such as complement, collectins, pentraxins, and ficolins, the C region engages Fc receptors (FcRs) from various innate effector cells to maximize antigen clearance (Chorny et al., 2016; Holmskov et al., 2003) .
Humoral immunity also involves IgD, an antibody with enigmatic effector function (Chen et al., 2009; Choi et al., 2017; Rouaud et al., 2014) . IgD emerged with IgM at the time of the inception of the adaptive immune system, when the lack of FcRs may have forced antibodies to develop FcR-independent defensive strategies (Flajnik, 2018) . Unlike IgM but similar to the mucosal antibody IgA, IgD does not recruit pro-inflammatory complement proteins (Gutzeit et al., 2018; Lu et al., 2018) , raising the possibility that IgD may have diverged from IgM to implement non-inflammatory protection at mucosal sites of antigen entry, including gills in fishes and nasopharyngeal cavities in mammals (Gutzeit et al., 2018) . This response could involve IgD recruitment of lectins (Holmskov et al., 2003) .
IgD is best known for its function as a B cell antigen receptor (BCR) (Gutzeit et al., 2018) . Mature B cells emerging from the bone marrow acquire IgD receptors of the same specificity as IgM receptors through alternative splicing of a long precursor mRNA (Gutzeit et al., 2018) . IgD and IgM receptor engagement by antigen initiates cognate B cell interactions with T follicular helper (Tfh) cells at the T-B follicular border (Victora and Nussenzweig, 2012) . B cells emerging from these interactions downregulate surface IgD and either differentiate into short-lived extrafollicular IgM-secreting plasma cells or enter a germinal center (GC) program fostering somatic hypermutation (SHM) and class switch DNA recombination (CSR), which are dependent on the DNA-editing enzyme activation-induced cytidine deaminase (AID) (Victora and Nussenzweig, 2012) . While SHM introduces point mutations within V region-encoding V(D)J genes to promote the selection of high-affinity BCRs, CSR replaces Cm with Cg, Ca, or Cε genes encoding the C H region of IgM, IgG, IgA, or IgE to diversify the antibody effector functions. Besides inducing memory B cells, the GC generates long-lived plasma cells that usually home to the bone marrow (Victora and Nussenzweig, 2012) .
Additional plasma cells secrete IgD in nasopharyngeal lymphoid tissues after undergoing CSR from Cm to Cd (Chen et al., 2009; Choi et al., 2017; Rouaud et al., 2014) . In humans, secreted IgD binds to basophils and, when cross-linked in vitro, activates basophil release of interleukin-4 (IL-4) through a yet unknown IgD receptor (IgDR) (Chen et al., 2009; Gutzeit et al., 2018) . Together with IL-5 and IL-13, the T helper type 2 (Th2) cytokine IL-4 promotes dendritic cell-orchestrated B cell responses involving IgG1 (in mice) or IgG4 (in humans) and IgE production (Wynn, 2015) . Of note, IgE protects against toxins and helminths and does so in cooperation with basophils and mast cells (Karasuyama et al., 2009; Palm et al., 2013) . Although early studies suggest that secreted IgD also plays an immuneamplifying role (Gutzeit et al., 2018; Xue et al., 1984) , the specific contribution of IgD to immunity remains elusive.
In this report we have shown that B cells mounted early IgD responses upon exposure to small soluble antigens such as food proteins. Secreted IgD bound to basophils and mast cells after interacting with galectin-9, a galactose-binding lectin that linked IgD with the immunomodulating proteoglycan CD44. Ligation of basophil-bound IgD by antigen triggered a basophil-regulated Th2 cell-mediated protective program that enhanced B cell production of antigen-specific IgG1 and IgE while decreasing IgE-induced basophil degranulation. Thus, secreted IgD may link B cells with basophils to maximize Th2 cell-mediated immune surveillance against common soluble antigens.
RESULTS

IgD Enhances Basophil Expression of IL-4
We first verified whether IgD elicited basophil release of IL-4 in vivo. As shown by ELISA, serum IgD was detected in wildtype (WT) but not control IgD-deficient (Ighd À/À ) mice and its concentration was higher in Th2 cell-biased BALB/c than Th1 cell-biased C57BL/6 strains ( Figure 1A ). Standard and imaging flow cytometry (FCM) assays detected both surface and intracellular IgD in a subset of basophils from various tissues of WT BALB/c mice ( Figures 1B, 1D , and S1A). Next, we analyzed basophils in IgD-deficient Ighd À/À mice, which have a largely normal immune system (Roes and Rajewsky, 1993) . These mice were crossed with Il4 GFP reporter mice, which express green-fluorescent protein (GFP) in response to Il4 activation (Mohrs et al., 2001) . FCM showed that Ighd À/À mice had fewer peripheral but not bone marrow basophils and that peripheral basophils from Ighd À/À Il4 GFP mice expressed less IL-4 compared to controls (Figures 1E and 1F) . Consistent with the involvement of basophils in Th2 cell-mediated immunity (Karasuyama et al., 2009) , Ighd À/À mice also had less serum IL-4
and IL-13 compared to controls ( Figure 1G ). Thus, IgD binds to basophils and increases basophil expression of IL-4.
IgD Ligation by Antigen Activates Basophils
Next, we determined whether basophil expression of IL-4 increases upon IgD ligation by antigen. IgD-deficient mMT or Rag2 À/À mice, which lack B cells or both B and T cells, respectively, were reconstituted with IgD secreted by B1-d8 cells , an IgD class-switched hybridoma specific for the hapten 4-hydroxy-3-nitrophenylacetyl (NP) (Neuberger and Rajewsky, 1981) . As shown by FCM, NP-specific IgD (NP-IgD) bound splenic basophils following intravenous (i.v.) administration into mMT mice ( Figures 1H and 1I ). Nonspecific ligation of basophil-bound NP-IgD following intraperitoneal (i.p.) injection of a goat polyclonal antibody to IgD (anti-IgD) induced downregulation of basophil-bound NP-IgD as well as expansion and activation of splenic basophils from IgD-reconstituted mMT mice, including increased basophil expression of CD200R3 (Figures 1I, 1J, and S1F) . Similarly, specific ligation of basophilbound NP-IgD by NP-haptenated ovalbumin (NP-OVA) made available by intranasal (i.n.) inoculation stimulated an increase of both the frequency and IL-4 expression of lung basophils from IgD-reconstituted Rag2 À/À mice ( Figures 1K and S1F ).
Having shown that IgD ligation by antigen enhanced basophil expression of IL-4 and knowing that some oral antigens initiate IL-3-independent Th2 cell-mediated responses through the epithelial cytokine thymic stromal lymphopoietin (TSLP) (Siracusa et al., 2011) , we verified whether IgD modulated IL-4 expression by lung basophils exposed to exogenous TSLP. Compared to controls, Ighd À/À mice inoculated with i.n. TSLP showed fewer lung basophils, which bound less IgE and expressed less IL-4 ( Figure 1L ). The functional relationship between IgD and TSLP was consistent with the detection of TSLP in human tonsillar districts inhabited by IgD + IgM À plasma cells ( Figure S1G ). These data suggest that TSLP stimulates B cell release of IgD in the context of an IgE-inducing humoral Th2 cell-mediated response involving IL-4 expression by basophils. This conclusion was further strengthened by the observation that i.v. inoculation of a TSLP-encoding plasmid strongly induced serum IgD ( Figure 1M ). Thus, ligation of basophil-bound IgD by antigen may enhance humoral Th2 cell immunity through a mucosal TSLP-regulated mechanism involving increased basophil expression of IL-4.
IgD Enhances Some but Not All Humoral Th2 Cell Responses
The Th2 cell-amplifying function of IgD was further evaluated in a subcutaneous (s.c.) immunization model involving co-inoculation of NP-OVA with exogenous NP-IgD or papain (Figure 2A ), a Th2 cell-inducing protease that activates basophils (Karasuyama Results are presented as mean ± SEM; *p < 0.05, **p < 0.01 (two-tailed unpaired Student's t test). See also Figure S1 . Figure 2I ), a Th2 cell-polarizing adjuvant distinct from papain (Wynn, 2015) . Finally, NP-specific IgG2a and IgG2b were increased in Ighd À/À mice s.c. immunized with NP-OVA and the Th1 cell-polarizing complete Freund adjuvant (CFA) ( Figure 2J ). Thus, IgD enhances some but not all humoral Th2 cell-mediated responses through a mechanism involving basophils.
IgD Increases Th2 Cell Polarization in Germinal Centers
The humoral Th2 cell-inducing function of IgD was further explored in a papain-adjuvanted intraperitoneal (i.p.) immunization model. ELISAs showed that, compared to WT controls, Ighd À/À mice induced less IgG1 and IgE specific to OVA upon i.p. immunization with NP-OVA and papain (Figures 3A and 3B) . This effect did not stem from depletion of Tfh cells or T follicular regulatory (TFR) cells (Victora and Nussenzweig, 2012 S4A , and S4B), a mucosal site exposed to both airborne and oral antigens. Accordingly, ELISA showed that serum IgD antibodies recognized milkderived a-s-casein, b-lactoglobulin, and a-lactalbumin and indeed were more abundant in children with food proteininduced enterocolitis syndrome (FPIES) exposed to milk compared to FPIES children under dietary milk restriction (Figure 4E) . Finally, FCM detected IgD on both tonsillar and circulating basophils ( Figure 4F ). Thus, IgD may arm basophils with an adaptive immune recognition system for common small soluble antigens, including food proteins.
IgD Induces Basophil Th2 Cell-like Responses but Inhibits Cytoskeleton Remodeling
Given that anti-IgD upregulates IL-4 expression by IgD-coated mouse basophils, we analyzed the gene expression profile of IgD-coated human basophils exposed to anti-IgD by gene microarray. Anti-IgD down-and upregulated 66 and 106 basophil transcripts, respectively (Figures 4G and S4C; Table S1 ). Gene set enrichment analysis followed by gene ontology analysis found that anti-IgD induced coordinated gene sets implicated in Th2 cell-mediated immunity, chemotaxis, inflammation, and signaling, including genes encoding IL-4 and IL-13 (Figures 4H  and 4I; Table S1 ). In addition, anti-IgD inhibited gene sets implicated in cytoskeleton remodeling via phosphoinositide 3-kinase (PI3-K), RAS, and small GTPases (Figures 4H and 4I; Table S1 ). Thus, IgD ligation stimulates transcriptional programs that mediate basophil induction of Th2 cell-associated cytokines as well as basophil inhibition of cytoskeleton remodeling, which might have a negative influence on granule mobilization.
IgD Binds to Basophils via Galectin-9 and CD44
Next, we explored how IgD binds to human basophils by studying IgD-associated proteins obtained by immunoprecipitation (IP). These proteins were identified by mass spectrometry and thereafter correlated with changes of their corresponding transcript upon basophil stimulation with anti-IgD ( Figure 4J ). Group A proteins mediated receptor stabilization, cytokine induction, inhibition of degranulation (galectin-9), autophagy (galectin-8), suppression of inflammation (annexin-1), iron metabolism, antibody binding, cell activation (transferrin receptor C or CD71), and endocytosis (CD36). Group B proteins mediated clathrinmediated receptor endocytosis and intracellular trafficking, whereas group C proteins encompassed both positive and negative regulators of receptor-mediated signaling (e.g., LYN). Finally, group D proteins mediated receptor anchoring to the cytoskeleton and cytoskeleton remodeling. Of note, IgD ligation by anti-IgD transcriptionally upregulated degranulation inhibitors such as galectin-9 (Niki et al., 2009) but downregulated degranulation inducers such as LYN (Gould and Sutton, 2008) (Figure 4J ). Given its ability to bind IgE (Niki et al., 2009 ), galectin-9 was further explored in relationship to its capacity to recognize IgD. IP followed by immunoblotting (IB) showed that human IgD interacted with galectin-9 through a mechanism that was blocked by galactose and lactose but not glucose ( Figure 5A ). In addition, FCM demonstrated that the human IgD-galectin-9 complex bound to human basophillike KU812 cells more effectively than IgD alone did and showed that this binding decreased upon incubation of KU812 cells with lactose but not glucose (Figures 5B and 5C) .
As shown by recently published studies (Panda et al., 2018; Wu et al., 2014) , additional experiments indicated that galectin-9 linked IgD to basophils via CD44. Indeed, the pre-formed IgD-galectin-9 complex bound less to KU812 cells after knocking down CD44 expression through RNA interference ( Figure 5D ). Accordingly, imaging FCM and confocal microscopy showed co-localization of IgD with galectin-9 and CD44 in human basophils (Figures 5E , S4D, and S4E). Finally, FCM and ELISA showed that, compared to untreated controls, human basophils stripped of pre-bound endogenous IgD and later incubated with a preformed exogenous IgD-galectin-9 complex displayed more surface IgD and secreted more IL-4 upon IgD ligation (Figures 5F and 5G) . In the absence of IgD ligation, the basophil-bound IgD-galectin-9 complex induced little or no IL-4 ( Figure 5G ).
Consistent with these data, IgD-coated basophils were reduced in the spleen and/or lung of galectin-9-deficient Lgals9 À/À or CD44-deficient Cd44 À/À mice ( Figures 5H and 5I ).
showed weaker NP-specific IgE and IgG1 responses following s.c. immunization with NP-OVA and papain, whereas in Lgals9 À/À mice such responses decreased in a non-significant manner ( Figures 5J and 5K ). This marginal decrease could indicate that IgD binds to different tandem-repeat galectins depending on the immunization route (Rabinovich and Toscano, 2009 ). In agreement with this possibility, ELISAs showed that mouse NPIgD bound to tandem-repeat galectin-4 in addition to galectin-9 but neither to prototypic galectin-1 and galectin-7 nor chimeric galectin-3 nor sialic acid-binding immunoglobulin-type lectin-1 (SIGLEC-1), SIGLEC-2, SIGLEC-E, or SIGLEC-F ( Figure S5A ). Given our earlier data showing that mouse basophils upregulated galectin-9 and that anti-IgD elicited basophil-regulated humoral Th2 cell-mediated responses, we measured IgG1 and IgE induction by anti-IgD in Lgals9 À/À mice. These mice showed no induction of serum IgG1 and IgE following i.p. injection of antiIgD ( Figure 5L ). In contrast, IgG1 and IgE were comparable in anti-IgD-treated WT DBA controls and Fcer1a À/À mice (Figure S5B) , which lack the IgE-binding and IL-4-inducing FcεRI receptor (Gould and Sutton, 2008) . Notwithstanding the existence of evidence indicating IgE interaction with galectin-9 and FcεRI modulation by CD44 (Kim et al., 2008; Niki et al., 2009 ), these findings make unlikely an involvement of FcεRI in IgG1 and IgE induction by anti-IgD. In agreement with earlier data obtained with human basophils, FCM and ELISA showed that mouse basophils bound NP-IgD-galectin-9 but not NP-IgD and that NPIgD-galectin-9 ligation by NP-OVA enhanced IL-3-induced basophil release of IL-4, IL-5, and IL-13 ( Figure S5C and S5D) . Thus, IgD binds galectin-9, which could interact with glycans from IgD and CD44 through two distinct carbohydrate-recognition domains (CRDs) (Rabinovich and Toscano, 2009) . In this way, galectin-9 may bridge IgD to a CD44-stabilized, clathrincoated, and cytoskeleton-linked IgD receptor (IgDR) complex that may also include CD71 ( Figure S5E ), a signal-transducing transferrin and IgA1 receptor (Chen et al., 2015; Mkaddem et al., 2014) . Besides being endocytosed into antigen-degrading compartments, this IgDR complex may induce IL-4, IL-5, and IL-13 release via multiple signal transducers ( Figure S5E ), including LYN (Gould and Sutton, 2008) .
IgD Inhibits IgE-Mediated Basophil Degranulation
Besides enhancing humoral Th2 cell-mediated responses, cross-linking of human IgD inhibited basophil gene programs linked to IgE-induced degranulation, which occurs upon secondary exposure to IgE-targeted antigens (Gould and Sutton, 2008) . basophils, more lung eosinophils, and more serum Mcpt8 (Figures 6D-6I ), a product of basophil degranulation. The inhibition of IgE-induced basophil degranulation by IgD was further explored in humans. Compared to healthy individuals, beekeepers tolerant to the bee venom antigen phospholipase A2 (PLA2) showed increased serum IgD to PLA2, but conserved IgD to tetanus toxin and reduced total IgD ( Figure 7A) . Protective PLA2-specific responses further included IgE and IgG4 ( Figure 7A ), which is equivalent to mouse IgG1 (Gould and Sutton, 2008) . Similarly, milk-allergic children treated for 12 months with oral immunotherapy (OIT) mounted increased IgD responses to a-s-casein and b-lactoglobulin compared to placebo-treated controls ( Figure 7B ). Moreover, egg-allergic children treated for 22 months with OIT mounted increased IgD responses to OVA compared to placebo controls ( Figure 7C ). In this OIT group, OVA-reactive IgD was increased in desensitized children but not in children unresponsive to OIT or with sustained tolerance to an OVA challenge ( Figure 7C ).
Next, we stimulated human basophils with F(ab')2 anti-IgE with or without F(ab')2 anti-IgD for 2 hr to assess the role of IgD ligation in IgE-induced degranulation. IgD ligation downregulated 227 and upregulated 180 transcripts in IgE-co-stimulated basophils, including mRNA encoding the signaling inhibitor dual specificity protein phosphatase 2 ( Figures 7D and S6A) . Gene set enrichment analysis followed by gene ontology analysis further determined that IgD ligation inhibited IgE-induced coordinated gene sets implicated in cytoskeleton remodeling, including mRNAs related to phospoinoside-3 kinase (PI3K), RAS, and RHO signaling ( Figure 7E ). Accordingly, IgD ligation impaired IgE-induced surface relocation of the granule-associated protein CD63 as well as extracellular release of the granule-associated pro-inflammatory mediator histamine in IL-3-co-stimulated human basophils ( Figures 7F and 7G) .
Similar results were obtained in human basophil-like KU812 cells pre-coated with NP-reactive IgE and IgD. Co-ligation of IgD by NP-OVA reduced IgE-induced basophil release of the granule-associated enzyme b-hexosaminidase, but increased basophil release of galectin-9 ( Figure 7H ). Like basophils (Chen et al., 2009) , human mast cells were proximal to tonsillar IgDsecreting plasma cells, exhibited surface IgD and galectin-9, and attenuated anti-IgE-induced degranulation upon exposure to anti-IgD (Figures S6B-S6E) . Thus, basophil-bound IgD not only enhances Th2 cell-mediated IgG and IgE responses, but also mitigates IgE-induced basophil and mast cell degranulation. Besides competing with IgE for antigen, basophil-bound IgD may inhibit IgE-mediated cytoskeleton remodeling and degranulation by inducing inhibitors of FcεRI signaling (Figures S6F and S7) .
DISCUSSION
We have shown here that certain soluble antigens induced plasma cells secreting IgD. This antibody bound to basophils through the CD44-interacting protein galectin-9. Ligation of secreted IgD by antigen increased basophil release of IL-4, IL-5 and IL-13, which promoted Tfh cell-dependent B cell production of IgE as well as IgG1 with high affinity for the antigen initially targeted by IgD. Besides amplifying humoral Th2 cellmediated responses, basophil-bound IgD attenuated IgEinduced basophil degranulation. In this way, IgD may dampen the immunogenicity of innocuous environmental antigens.
Antibodies regulate immunity in addition to neutralizing and clearing antigen. Indeed, mouse studies have shown that IgM and IgG3 increase antibody responses through complement receptors, whereas IgG1, IgG2a, IgG2b, IgA, and IgE enhance or suppress antibody responses via FcRs (Lu et al., 2018) . The role of IgD remains unknown, but pioneering works suggest that IgD amplifies humoral immunity through glycans from the Cd1 and Cd3 domains (Amin et al., 1993; Gutzeit et al., 2018; Xue et al., 1984) . Accordingly, we found that IgD augmented IgG1 and IgE responses through a mechanism involving IgD binding to basophils via galectin-9, a lectin encompassing two distinct CRDs (Rabinovich and Toscano, 2009 ). This protein bridged IgD with CD44, an immunomodulatory receptor expressed by activated immune cells, including basophils (Kim et al., 2008; Panda et al., 2018; Wu et al., 2014) .
Besides binding to galectin-9, IgD interacted with galectin-4 and possibly galectin-8, which are tandem repeat galectin subfamily members similar to galectin-9 (Rabinovich and Toscano, 2009 ). However, IgD did not interact with galectin-1, galectin-3, and galectin-7, which belong to the prototypic or chimeric galectin subfamilies (Rabinovich and Toscano, 2009 ). This binding pattern may confer specific tissue or cell tropism to IgD while preserving its functional flexibility. Consistently, the number of lung but not spleen IgD-coated basophils decreased in galectin-9-deficient mice. In contrast, both spleen and lung IgD-coated basophils were undetectable in CD44-deficient mice, suggesting that CD44 represents a common acceptor molecule for multiple tandem repeat galectins. As suggested by published studies (Kim et al., 2008; Niki et al., 2009; Wu et al., 2014) , these lectins may link IgD to CD44 to stabilize a basophil IgDR complex that regulates cytokine secretion and degranulation.
Although broadly expressed by activated immune cells, CD44 may generate context-dependent signals by clustering with specific receptors, such as FcεRI from basophils and mast cells (Kim et al., 2008; Niki et al., 2009 ). However, IgD did not require FcεRI to enhance humoral Th2 cell-mediated responses, which indeed were conserved in anti-IgD-treated Fcer1a À/À mice. Yet, IgD might leverage the CD44-binding properties of galectin-9 to modulate other FcεRI-induced functions, including degranulation (Kim et al., 2008; Niki et al., 2009 ). In addition to transmitting autonomous immunomodulating signals (Panda et al., 2018) , CD44 interacts with the immunoregulatory TGF-b receptor to stabilize its functional output (Wu et al., 2014) . This implies that IgD may engage signal-transducing proteins additional to CD44. In agreement with this possibility, IgD co-immunoprecipitated with the CD71 transferrin receptor, which delivers activating signals in addition to regulating iron metabolism (Chen et al., 2015) . Besides transferrin, CD71 binds monomeric IgA1 and does so through glycans similar to those associated with IgD (Swenson et al., 1998; Mkaddem et al., 2014) . Of note, CD71 undergoes ligation-induced endocytosis via clathrin-coated vesicles (Kaksonen and Roux, 2018) . Accordingly, IgD also associated with clathrin, the clathrin adaptor protein AP-2, and the ADP-ribosylation factor ARF1, a regulator of clathrin-mediated endosomal trafficking (Kaksonen and Roux, 2018) . Thus, besides delivering basophil-regulating signals via CD44 and possibly CD71, the IgDR complex may internalize IgD-bound antigens by undergoing clathrin-mediated endocytosis. This scenario is supported by our findings showing IgD co-localization with galectin-9 and CD44 within basophil membrane, sub-membrane, as well as intracellular compartments and could account for the rapid degradation of IgD-bound antigens within endosomes from basophils as well as mast cells.
In mice, basophil release of IL-4, IL-5, and IL-13 followed engagement of IgD by antigen. In humans, proximal signaling elements of this pathway may include LYN, which mediates IL-4-inducing signals from the high-affinity IgER, commonly known as FcεRI (Gould and Sutton, 2008) . In addition to IL-4, crosslinking of human basophil-bound IgD upregulated Th2 cell response-related genes such as IL-9 and IL-13. This finding correlated with the ability of mouse basophils to enhance Th2 cell-type IgG1 and IgE responses upon IgD ligation by antigen. It also echoed early studies showing that IgD has immuneamplifying properties that encompass antibody induction (Xue et al., 1984) .
In mice, secreted IgD was sufficient to enhance some but not all IgG1 and IgE responses through an AID-mediated GC pathway involving IL-4-expressing Tfh cells. Indeed, IgG1 production decreased in Ighd À/À mice immunized with the basophil-activating adjuvant papain, but not in those with the dendritic cell-activating adjuvant alum (Karasuyama et al., 2009; Wynn, 2015) . The phenotype of Ighd À/À mice correlated with decreased basophil expression of IL-4, impaired IgG1 and IgE class switching, and reduced IgG1 affinity maturation. However, Ighd À/À mice restored this antigen-specific response as well as that non-specifically induced by anti-IgD following reconstitution with secreted IgD. Thus, IgD can deploy basophil-regulated antibody-enhancing signals independently of its BCR function. Secreted IgD mimicked the Th2 cell-inducing properties of papain by inducing basophil recruitment and upregulation of IL-4, IL-5, and IL-13 upon engagement by antigen and this response correlated with the early emergence of extrafollicular IgD-secreting plasma cells. Unlike their murine counterparts (Rouaud et al., 2014) , human IgD + IgM À plasma cells are highly mutated (Gutzeit et al., 2018) , which could reflect chronic exposure of mucosal IgD-inductive sites to food antigens (Chen et al., 2009; Choi et al., 2017) . In this regard, we found that children consuming cow's milk with their diet had more serum IgD to milk proteins compared to children restricting milk from their diet. Thus, food antigens may constitute a major target of humoral IgD responses in humans. The Th2 cell-inducing nature of mouse IgD responses to mucosal antigens was suggested by the homeostatically elevated serum concentration of IgD in Th2 cell-biased BALB/c mice compared to Th1 cell-biased C57BL/6 mice and by the induction of IgD in mice inoculated with exogenous TSLP, a Th2 cell-inducing mucosal cytokine that triggers basophil activation in an IL-3-independent manner (Siracusa et al., 2011) . Besides eliciting basophil release of Th2 cell-associated cytokines, IgD constrained IgE-mediated basophil and mast cell degranulation. Accordingly, IgD deficiency enhanced OVAinduced acute lung inflammation as well as basophil degranulation in OVA-sensitized Ighd À/À mice. Conversely, OVA-specific IgD increased in allergic children desensitized to OVA by OIT. Similarly, beekeepers tolerant to the bee venom toxin PLA2 mounted enhanced PLA2-specific IgD responses. As also shown by others (Palm et al., 2013) , beekeepers additionally produced PLA2-specific IgE and IgG4, which is the human equivalent of mouse IgG1 and a hallmark of protection against allergy (Gould and Sutton, 2008) . Thus, IgD may co-emerge with IgE from a protective Th2 cell pathway targeting some soluble antigens. How IgD mitigates degranulation remains unclear, but IgD ligation downregulated the expression of basophil gene products involved in IgE-mediated cytoskeleton remodeling and granule exocytosis (Gould and Sutton, 2008) , including the signal transducers phosphoinositide-3 kinase, RAS, and RHO. Concomitantly, IgD upregulated the expression of basophil gene products encoding signal inhibitors such as DUSP2. Finally, the association of IgD with the synaptosome-associated protein of 23 kDa SNAP23 suggests that IgD could also modulate the docking of granules to the plasma membrane of basophils.
In summary, our data show that some common antigens, such as certain food proteins, induce B cell release of IgD, which binds to basophils through the CD44-interacting protein galectin-9. By eliciting basophil release of IL-4, IL-5, and IL-13, IgD promotes protective humoral Th2 cell-mediated responses while constraining IgE-mediated basophil degranulation. Thus, IgD-harnessing strategies, including administration of galectin-9 (de Kivit et al., 2012) , could attenuate acute IgE-dependent allergic reactions to food antigens and might represent a revolutionizing approach to allergy prophylaxis.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Blood and Tissue Specimens Plasma samples were collected from children (5-11 years of age) with FPIES undergoing a supervised food challenge. In this cohort, 5 children were restricting milk from their diet due to history of milk-related FPIES but passed the food challenge, whereas 5 children were not due to milk-unrelated FPIES. Additional plasma samples were collected from 55 children (5-11 years of age) with egg allergy enrolled in a double-blind placebo-controlled OIT trial. In this trial, 40 children received daily OIT with egg white powder, whereas 15 children received placebo control. In the OIT group, a dose escalation phase was followed by a maintenance phase of 2 g egg white powder daily. All participants underwent an oral food challenge at 10 months with a 5 g cumulative dose of egg white powder. Children in the OIT group continued treatment and underwent a second oral food challenge at 22 months with a cumulative dose of 10 g egg white powder. Those who passed the 22 month challenge without symptoms discontinued OIT for 4-6 weeks and underwent a third oral food challenge at 24 months to determine if desensitization was sustained. Subjects were categorized as having failed treatment if they were unable to tolerate OIT or if they reacted during the challenge at 22 months (n = 10). Subjects passing the challenge at 22 months but reacting to the challenge at 24 months were categorized as desensitized (n = 19). Subjects passing the challenge at both time-points were categorized as having sustained unresponsiveness (n = 11). More plasma samples were collected from 4 beekeepers and 4 age-matched healthy donors. 
METHOD DETAILS Cells
Human basophils were purified from circulating or tonsillar mononuclear cells by Ficoll density centrifugation followed by negative selection using EasySep Human Basophil Enrichment kit (Stem Cell Technologies). Basophil purity was > 98% and viability ranged from 90% to 95%. Human B cells were analyzed as in published studies (Chen et al., 2009) . Mouse mononuclear cells were isolated from spleen, lung, lymph nodes and bone marrow as reported previously (Shan et al., 2013) . CD45
Standard Flow Cytometry
Cells were stained with various combinations of monoclonal antibodies (mAbs) or polyclonal antibodies (pAbs) (Tables S2 and S3 ). Cells were incubated at 4 C with Fc-blocking reagent (Miltenyi Biotec) before the addition of the appropriate 'cocktails' of fluorochrome-labeled mAbs or pAbs. A BD Cytofix/Cytoperm Kit was used to perform intracellular stainings (BD Biosciences). 4'-6-diamindine-2 0 -phenylindole (DAPI; Boehringer Mannheim), 7-aminoactinomycin D (7-AAD; BD PharMingen), or Live-Dead Kit (Invitrogen) were used to exclude dead cells and all gates were drawn to give % 1% positive cells in the sample stained with control antibodies. Cells were acquired with a BD LSR Fortessa Cell Analyzer (BD Biosciences) and data were analyzed with FlowJo V10 software (TreeStar).
Imaging Flow Cytometry
Untouched human basophils were stripped of pre-bound endogenous IgD as described in published studies (Chen et al., 2009 ) and incubated in PBS with or without 50 mg/mL monoclonal IgD from human myeloma (Athens Research and Technology), 2.5 mg/mL galectin-9 (R&D Systems), or 50 mg/mL IgD pre-mixed with 2.5 mg/mL galectin-9 on ice for 15 min. Following washing, basophils were sequentially stained with F(ab)2 to IgD biotin (Southern Biotech) and streptavidin (Life Technologies) along with anti-FcERI FITC (clone: AER-37; eBioscience) and anti-CD44 PE (clone: IM7; Biolegend). Following additional washing, stained cells were fixed with 1% paraformaldehyde, stained with 100 ng/mL DAPI (Sigma-Aldrich), and imaged. A similar strategy was used to image basophils included in splenocytes from BALB/c mice. These cells were incubated with an Fc-blocking 2.4G2 mAb (Tonbo Bioscience) and subsequently stained with anti-FcERI FITC (clone: MAR-1), anti-IgD PE (clone: 11-26c.2a) (BD Biosciences), anti-CD49b APC (clone: DX5) (Biolegend), and Ghost Violet 510 viability dye (Tonbo Bioscience). Following washing, stained cells were fixed with 1% paraformaldehyde and stained with 5 mg/mL 7-AAD (Tonbo Bioscience).
FACSorting
For human basophil sorting, cell suspensions were incubated at 4 C with Fc-blocking reagent (Miltenyi Biotec) or blocking 2.4G2 mAb to FcgRIII/II (BD PharMingen) and then stained for 30 min with the following antibody combination: anti-CD45 AF700 (clone: HI30), anti-FcεRI FITC (clone: CRA1), anti-CD123 PE (clone: 6H6), anti-HLA-DR PerCpCy5.5 (clone: L243), anti-CD19 eFluor450 (clone: HIB19), anti-IgD PE-Cy7 (clone: IA6-2). Basophils were sorted with a FACSAria II (BD Biosciences) after exclusion of dead cells through DAPI staining. The purity of cells sorted this way was consistently > 95%.
Cell and Tissue Imaging
Human and mouse cells were imaged using an Amnis ImageStream X Mark II imaging flow cytometer (EMD Millipore) and data were analyzed using IDEAS 6.1 (EMD Millipore) after excluding non-single cells and cells out of focus. Human and mouse tissue sections were processed as reported previously (Shan et al., 2013) . Briefly, formalin-fixed paraffin-embedded (FFPE) human or mouse tissue sections were treated with xylene, a decreasing alcohol gradient, and distilled water to rehydrate the tissue. Heat-induced epitope retrieval was performed for 15 min. in citrate buffer (pH 6) or Tris-EDTA (pH 9). Antigen-retrieved FFPE or OCT-embedded tissue sections were processed as previously reported (Shan et al., 2013) and stained with various combinations of mAbs and/or pAbs (Tables  S2 and S3 ). Biotinylated antibodies were detected with streptavidin-Alexa Fluor conjugates. Nuclear DNA was visualized with DAPI and coverslips were applied with FluorSave reagent (Merck Millipore) or ProLong Gold Antifade reagent (Invitrogen). Fluorescent images were acquired with a Leica TCS SP5 Upright laser scanning confocal microscope (Leica Microsystems) and further analyzed with ImageJ software. Alternatively, images were acquired with an epi-fluorescence Eclipse Ni-U microscope (Nikon Instruments) with NIS Elements BR software (Nikon Instruments).
Mass Spectrometry
To identify the IgD receptor, buffy coats from five healthy donors provided by the New York Blood Bank were pooled and processed with a Basophil Isolation Kit (Miltenyi Biotech) to MACSort 20 3 10 6 circulating basophils (purity > 95%). Cells were divided into two 10 3 10 6 fractions. In the first fraction, basophils were incubated with a biotinylated goat 2032-08 F(ab')2 pAb to IgD (Southern Biotech) to label pre-bound IgD. In the second fraction, basophils were treated with biotinylated 0110-08 goat F(ab')2 control IgG (Southern Biotech). These fractions were lysed in a buffer containing 1% NP-40 and supernatants immunoprecipitated with streptavidin-conjugated Sepharose beads (GE Healthcare). Immunoprecipitated proteins were resolved by one-dimensional SDS-PAGE and stained by SYPRO Ruby. Differentially immunoprecipitated protein bands were identified using a 4000 Q Trap (SciEx) mass spectrometer.
Binding Assays
Primary circulating human basophils were first stripped of pre-bound endogenous IgD as previously described (Chen et al., 2009 ) and then incubated for 15 min with 50 mg/mL monoclonal IgD (Athens Research and Technology) pre-mixed or not with 10 mg/mL galectin-9 (R&D Systems) for 15 min. Binding of IgD was detected by staining cells with FITC-conjugated goat 2032-02 F(ab')2 pAb to IgD (Southern Biotech) or control FITC-conjugated goat F(ab')2 IgG. A similar method was followed to measure binding of exogenous IgD or IgD-galectin-9 to human basophil-like KU812 cells, except that no stripping of endogenous pre-bound IgD was necessary.
Cultures and Reagents
Primary human or mouse basophils and human basophil-like KU812 cells were cultured in complete RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) (Life Technologies). Human basophils were stimulated with 30 ng/mL IL-3 (Prepotech). Endogenous IgD and IgE pre-bound to human basophils were cross-linked with 25 mg/mL anti-IgD (clone: IA6-2; BD Biosciences) and 2 mg/mL anti-IgE (clone: G7-18, BD Biosciences). As a control, basophils or KU812 cells were exposed to 25 mg/mL IgG2a pAb with irrelevant binding specificity (Santa Cruz Biotechnology). KU812 cells were also incubated with 1 mg/mL NP-OVA (Biosearch Technologies) before or after pre-incubation with 50 mg/mL control human IgE with irrelevant specificity (AbD Serotec), 50 mg/mL chimeric human NP-reactive IgE (AbD Serotec), and/or 50 mg/mL mouse NP-reactive IgD from B1-d8 hybridoma pre-complexed with 25 mg/mL human galectin-9 (R&D Systems). This binding strategy obviated the lack of human NP-reactive IgD and was based on preliminary data showing conserved binding of human or mouse galectin-9 to mouse or human IgD. Mouse basophils were stimulated with 10 ng/mL IL-3 (Prepotech), 1 mg/mL NP-conjugated OVA (Biosearch Technologies), 50 mg/mL mouse NP-reactive IgD pre-incubated or not with 25 mg/mL mouse galectin-9 (R&D Systems).
Cytometric Bead Arrays and ELISAs for Cytokine Measurements
A BD Cytometric Bead Array Th1Th2Th17 Cytokine Kit as well as Human IL-4IL-13 Quantikine ELISA (R&D Systems) kits were used to measure human IL-4. A Human Galectin-9 Quantikine ELISA (R&D Systems) was used to measure human galectin-9. A Histamine (HIS) ELISA kit and an Hexosaminidase A ELISA Kit (HEXA) (antibodies-online.com) were used to measure human histamine and a-hexosaminidase, respectively. Mouse Th1Th2Th17Th22 13 PLEX Kit (eBioscience) as well as Mouse IL-4IL-13IL-25IL-33 DuoSet ELISA (R&D Systems) kits were used to measure IL-4, IL-5, IL-13 and IL-21 from the serum of WT or IgD mice immunized with NP-OVA and papain or treated with anti-IgD before or after reconstitution with exogenous NP-IgD. A Mast Cell Protease 8 (MCPT8) ELISA Kit (antibodies-online.com) was used to measure mouse serum Mcpt8.
Global Transcriptome Analysis
Total cellular RNA was isolated with the RNeasy Micro kit (QIAGEN) from sorted basophils by following the manufacturer's protocol. RNA integrity was assessed using Agilent 2100 Bioanalyzer (Agilent). Amplification, labeling and hybridizations were performed according to the protocol GeneChip WT Pico Reagent Kit (P/N 703262, Rev.1 2015) and then hybridized to GeneChip Human Gene 2.0 ST Array (Thermo Fisher) in a GeneChip Hybridization Oven 640. Washing and scanning were performed using the Expression Wash, Stain and Scan User Manual (P/N 702731 Rev. 3) in the Affymetrix GeneChip System including GeneChip Fluidics Station 450 and GeneChip Scanner 3000 7G (Affymetrix). After quality control, raw data were background corrected, quantilenormalized and summarized to a gene-level using the robust multi-chip average (RMA) system. For the detection of differentially expressed genes, a linear model was fitted to the data and empirical Bayes moderated statistics were calculated using the limma package from Bioconductor Genes (Wettenhall et al., 2006 ) with a p value less than 0.05 and with an absolute fold change value above 1.5 were selected as significant. Analyses were performed with R (v.3.2.3) and standard packages. Functional analyses were performed using the Comparison Upstream Regulator Analysis tool in the Ingenuity Pathway Analysis package (Ingenuity Systems, www.ingenuity.com). Gene Set Enrichment Analysis was performed along with the Molecular Signature Database (MSigDB) (Subramanian et al., 2005) and used to identify similarities and differences among samples.
Immunoprecipitation and Immunoblotting
To determine IgD interaction with galectin-9 in a cell-free protein-protein assay, 2 mg/mL human monoclonal IgD from multiple myeloma (Athens Research and Technology) was mixed with 2 mg/mL human recombinant galectin-9 (R&D Systems) in the presence or absence of control PBS, glucose or lactose (Sigma) for 30 min. Then, this protein mix was first incubated with biotin-conjugated goat pAbs with either an irrelevant specificity or a specific reactivity against human IgD and later exposed to SA-coated Sepharose beads (Table S3) . Denatured proteins were fractionated by SDS-PAGE, transferred onto PVDF membranes, and immunoblotted with a mAb to galectin-9 (Table S3) . To analyze human IgD interaction with galectin-9 through CD44, 5 3 10 6 basophil-like KU812 cells were incubated with or without a pre-formed IgD-galectin-9 complex prepared as described earlier and then homogenized in lysis buffer with a Dounce homogeneizer. Next, equal amounts of protein lysates were sequentially incubated with goat biotin-conjugated pAb to human IgD and SA-coated beads. Denatured proteins were fractionated through SDS-PAGE, transferred onto PVDF membranes (BioRad) and immunoblotted with mAbs to human IgD, galectin-9 or CD44 (Table S3 ) and appropriate secondary antibodies as reported previously (Shan et al., 2013) . Proteins were detected with an enhanced chemiluminescence detection system (Amersham).
ELISAs
Total human IgD was measured with the Human IgD ELISA Quantitation Set (Bethyl Laboratories). To measure total human IgG4 and IgE, 96-well plates were first coated with 1 mg/mL mouse RJ4 or TN142 mAbs, respectively, and later sequentially incubated with plasma and 0.4 mg/mL horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG pAb (Pierce). To measure total mouse IgD, plates were first coated with goat 21-1281 pAb to mouse IgD (American Research Products) and later sequentially incubated with serum and HRP-conjugated goat 21-1284 pAb to mouse IgD (American Research Products). To measure human or mouse antigen-specific IgG, IgE or IgD, plates (Immulon 4HBX, Thermo Scientific) coated with 5 mg/mL NP (4)-BSA, NP (7) (Table S4) were incubated overnight at 4 C. OVA-specific IgE was measured through a LEGEND MAX Mouse OVA Specific IgE ELISA Kit (BioLegend). Diluted serum samples were added overnight at 4
. After washing the plates, horseradish peroxidase (HRP)-conjugated goat IgG pAbs to mouse IgG1, IgE, IgG2a, IgG2b (Southern Biotech) or IgD (American Research Product) were incubated for 2 h at room temperature. Plates were developed with TMB Microwell Peroxidase Substrate System (KPL) and read at 405 nm (Biotek Epoch) using Gen5 Microplate reader software 2.01. An appropriate control serum or IgD purified from he supernatants of the B1-d8 hybridoma were used as standards to quantify the concentration of total antibodies, whereas a hyper-immune serum was used as reference to calculate the concentration of antigen-specific antibodies. To detect the binding of mouse IgD to galectins or Siglecs, plates were first coated with 5 mg/mL mouse galectin-1, galectin-3, galectin-4, galectin-7, galectin 9, Siglec-1, Siglec-2, Siglec-E, or Siglec-F (R&D Systems). Next, coated plates were washed and incubated with serial 2-fold dilutions of IgD purified from the supernatants of the mouse IgD class-switched B1-d8 cells. Finally, plates were washed and incubated with HPR-conjugated goat anti-IgD (American Research Products). Wells coated with mouse IgD but no galectins or Siglecs were used as positive controls. Reactions were developed with the HRP substrate TMB (Life Technologies) and stopped with 2N H 2 SO 4 to measure optical density (OD) at 450 nm using a Berthold Mithras LB940 spectrophotometer (Berthold Technologies).
ELISPOT
MultiScreen HTS IP 0.45 mm ELISPOT plates (Millipore) were coated with 1 mg/mL NP-BSA or IgD in PBS. The next day, plates were washed twice with RPMI 1640 and blocked with 10% FCS in RPMI 1640 at 37 C for 2 h. Splenocytes were added to the wells and incubated overnight at 37 C in a 5% CO 2 incubator. The following day, cells were discarded and plates washed twice with deionized H 2 O and three times with PBS containing 0.1% Tween. Spots corresponding to ASCs were detected by adding an HRP-conjugated goat anti-mouse antibody and AEC Substrate Set (Beckton Dickinson). Color development was stopped with water and spots were counted using C.T.L. Immunospot (Cellular Technology Limited).
Isolation of Secreted IgD
Mouse NP-reactive IgD class-switched B1-d8 hybridoma cells (from Michael Neuberger, Cambridge University) were stained with FITC-conjugated 11-26c.2a mAb to IgD (BD PharMingen) and analyzed for IgD expression by FCM. Gated IgD hi cells were seeded at 1 cell/well into 96-well plates by FACSorting and cultured with RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) to obtain IgD hi subclones. More than 200 subclones were screened by ELISA and 4H11 was selected for elevated IgD but no IgM secretion and incubated into a CELLine CL1000 bioreactor to obtain large amounts of NP-specific IgD. To affinity purify IgD, concentrated supernatant was clarified by centrifugation at 3000 3 g for 60 min at 4 C, followed by filtration through a 0.22 mm Millex-GP filter (Merck Millipore). NP (Biosearch Technologies) was coupled to EAH Sepharose 4B (GE Healthcare) with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (Pierce). 0.5M of NaCl was added to the clarified supernatant that was incubated with NP-EAH Sepharose 4B overnight at 4 C with end over end rotation. Unbound material was washed using DPBS 0.5M NaCl and IgD was eluted with DPBS 4M MgCl 2 . Finally, IgD was concentrated using an Amicon Ultra-4 Centrifugal Filter Unit with Ultracel 50K membrane (Merck Millipore) and quantified by measuring absorbance at 280 nm. 1 mg/mL corresponded to an OD of 1.5. Concentrated IgD preparations did not contain endotoxin, which was measured using a QCL-1000 Limulus Amebocyte Lysate kit from Lonza (Catalogue Number 50-647U).
qRT-PCRs qRT-PCRs were performed as previously described (Shan et al., 2013) using appropriate primer pairs (Table S5) .
Immunizations
Mice were immunized by s.c. injection of 50 mg NP-OVAL (Bioresearch Technologies) and 50 mg papain from Carica papaya (Sigma) on day 0, 7 and 14; by s.c. injection of 50 mg NP-OVAL and Imject alum (Thermo Scientific) on day 0, 7 and 14; by s.c. injection of 50 mg NP-OVAL and 50 mg Imject CFA (Thermo Scientific) on day 0 followed by 50 mg NP-OVAL on day 7 and 14; by i.p. injection with 50 mg grade-VI NP-OVA (Sigma) and 50 mg papain (Sigma) on day 0 and 7; or by i.p. injection of 1 mg goat anti-mouse IgD or 1 mg control goat IgG.
IgD Reconstitution
IgD-deficient Ighd À/À or Ighd À/À Il4 GFP mice and B cell-deficient mMT or Rag2 mice were i.v. injected for 3-5 consecutive days before immunization (from day À5 to day À1) with 100 mg NP-IgD purified from NP-reactive IgD class-switched B1-d8 cells.
Basophil Depletion
Basophils from Mcpt8 DTR mice were depleted by i.v. injection of 2.5 mg DT (Sigma). Basophils from WT BALB/c mice were depleted by i.v. injection of 30 mg Ba103 mAb to CD200R3 (Hycult Biotech) for 5 consecutive days before immunization (from day À5 to day À1) and for 5 alternate days (from day 1 to day 9) after immunization. A rat IgG2b RTK4530 mAb (Hycult Biotech) was used as control.
Acute Lung Inflammation
Mice were sensitized through i.p. injection of 20 mg grade-V OVA (Sigma) mixed with 2 mg aluminum hydroxide gel (Invitrogen) on day 0, 7 and 14 and challenged through i.t. inoculation of 0.1% OVA or control sterile PBS on day 16, 18, 20 and 22. Bronchoalveolar (BAL) fluid, blood and lung cells were collected for analysis 4 and 24 h following the last i.t. challenge.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical significance was assessed with a two-tailed unpaired Student's t test. Mann-Whitney U-test and Wilcoxon matched-pairs signed-rank test were used for analysis of non-parametric data. Results were analyzed with Prism software (Graph Pad) and p values of less than 0.05 were considered significant.
DATA AND SOFTWARE AVAILABILITY
The Gene Expression Omnibus (GEO) accession number for the global gene transcriptional analysis reported in this paper is GSE115296.
